Filtered By:
Specialty: Drugs & Pharmacology
Condition: Epilepsy
This page shows you your search results in order of date. This is page number 6.
Order by Relevance | Date
Total 166 results found since Jan 2013.
A Review on the Arylpiperazine Derivatives as Potential Therapeutics for the Treatment of Various Neurological Disorders
Curr Drug Targets. 2022 Jan 17. doi: 10.2174/1389450123666220117104038. Online ahead of print.ABSTRACTNeurological disorders are disease conditions related to the neurons and central nervous system (CNS). Any kind of structural, electrical, biochemical and functional abnormalities in neurons can lead to various types of disorders like Alzheimer's disease (AD), depression, Parkinson's disease (PD), epilepsy, stroke, etc. Currently available medicines are symptomatic and do not treat the disease state. Thus, novel CNS active agents with the potential of complete treatment of an illness are highly desired. A range of small or...
Source: Current Drug Targets - March 21, 2022 Category: Drugs & Pharmacology Authors: Bhupinder Kumar Naveen Kumar Amandeep Thakur Vijay Kumar Rakesh Kumar Vinod Kumar Source Type: research
Pharmacological potential of JWH133, a cannabinoid type 2 receptor agonist in neurodegenerative, neurodevelopmental and neuropsychiatric diseases
Eur J Pharmacol. 2021 Jul 29:174398. doi: 10.1016/j.ejphar.2021.174398. Online ahead of print.ABSTRACTThe pharmacological activation of cannabinoid type 2 receptors (CB2R) gained attention due to its ability to mitigate neuroinflammatory events without eliciting psychotropic activities, a limiting factor for the drugs targeting cannabinoid type 1 receptors (CB1R). Therefore, ligands activating CB2R are receiving enormous importance for therapeutic targeting in numerous diseases including neurodegenerative, neuropsychiatric and neurodevelopmental disorders as well as traumatic injuries and neuropathic pain where neuroinflam...
Source: European Journal of Pharmacology - August 1, 2021 Category: Drugs & Pharmacology Authors: Hebaallah Mamdouh Hashiesh Niraj Kumar Jha Charu Sharma Piyush Kumar Gupta Saurabh Kumar Jha Chandragouda R Patil Sameer N Goyal Shreesh K Ojha Source Type: research
Dynamic nanoassemblies for imaging and therapy of neurological disorders
Adv Drug Deliv Rev. 2021 Jun 16:113832. doi: 10.1016/j.addr.2021.113832. Online ahead of print.ABSTRACTThe past decades have witnessed an increased incidence of neurological disorders (NDs) such as Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, ischemic stroke, and epilepsy, which significantly lower patients' life quality and increase the economic and social burden. Recently, nanomedicines composed of imaging and/or therapeutic agents have been explored to diagnose and/or treat NDs due to their enhanced bioavailability, blood-brain barrier (BBB) permeability, and targeting c...
Source: Advanced Drug Delivery Reviews - June 19, 2021 Category: Drugs & Pharmacology Authors: Lingxiao Zhang Heng Sun Jing Zhao Jiyoung Lee Liang Ee Low Linji Gong Ying Chen Nan Wang Chaojie Zhu Peihua Lin Zeyu Liang Min Wei Daishun Ling Fangyuan Li Source Type: research
Neuroprotective Potential of Caffeic Acid Phenethyl Ester (CAPE) in CNS Disorders: Mechanistic and Therapeutic Insights
Curr Neuropharmacol. 2021 Jun 8. doi: 10.2174/1570159X19666210608165509. Online ahead of print.ABSTRACTNeurological disorders like Alzheimer's disease (AD), Parkinson's disease (PD), stroke, amyotrophic lateral sclerosis, Huntington's disease (HD), epilepsy, traumatic brain injury (TBI), depression and anxiety are responsible for thousands of deaths worldwide every year. With the increase in life expectancy, there has been a rise in the prevalence of these disorders. Age is one of the major risk factors for these neurological disorders and with the aged population is set to rise to 1.25 billion by 2050. There is a growing ...
Source: Current Neuropharmacology - June 9, 2021 Category: Drugs & Pharmacology Authors: Namrata Pramod Kulkarni Bhupesh Vaidya Acharan Narula Shyam Sunder Sharma Source Type: research
